23
Views
8
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Progestins and cancer

&
Pages 3-9 | Published online: 28 Aug 2009

References

  • Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85:304–13
  • Key TJ. Progestins in postmenopausal women: epidemiological data on relationships with endo-metrial and breast cancer risk. In Sitruk-Ware R, Mishell D, eds. Progestins and Antiprogestins in Clinical Practice. New York: Marcel Dekker, 1999 (in press)
  • The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. J Am Med Assoc 1996;275:370–5
  • Woo druffJD, Pickar JH for the Menopause Study Group. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994;170:1213–23
  • Steinberg KK, Thacker SB, Smith SJ, et al. A meta-analysis of oestrogen replacement therapy and the risk of breast cancer. J Am Med Assoc 1991; 265:1985–90
  • Sitruk-Ware R, Plu-Bureau G. Progestogen use and breast cancer. In Wren BG, ed. Progress in the Management of Menopause. Carnforth, UK: Parthe-non Publishing, 1997:203–10
  • Key TJA, Pike MC. The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24: 29–43
  • Gambrell RD Jr, Maier R, Sanders B. Decreased incidence of breast cancer in postmenopausal oestrogen and progestogen? Obstet Gynecol 1983; 62:435–43
  • Nachtigall MJ, Smiler SW, Nachtigall RD, et al. Incidence of breast cancer in a 22 year study of women receiving estrogen—progestin replacement therapy. Obstet Gynecol 1992;80:827–30
  • Bergkvist L, Adami HO, Persson I, et al. The risk of breast cancer after oestrogen and oestrogen/ pro gestogen replacement. N Eng1J Med 1989;321: 293–7
  • Persson I, Yuen J, Bergkvist L, et al. Combined oestrogen—progestogen and breast cancer risk. Lancet 1992;340:1044
  • Ewertz M. Influence of non-contraceptive exoge-nous and endogenous sex hormones on breast can-cer risk in Denmark. Int J Cancer 1988;42:832–8
  • Colditz GA, Hankinson SE, Hunter DJ. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589–93
  • Newcomb PAA, Longnecker MP, Storer BE. Long term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788–95
  • Stanford JL, Weiss NS, Voigt LF. Combined estro-gen and pro gestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J Am Med Assoc 1995;574:137–42
  • Plu-Bureau G, Le MG, Sitruk-Ware R, et al. Pro-gestogen use and decreased risk ofbreast cancer in a cohort study of premenopausal women with benign breast disease. Br J Cancer 1994;70:270–7
  • Schindler AE, Campagnoli C, Druckmann R, et al. (European Progestin Club). Aspects of progestin activity on the breast. Maturitas 1998;29:61–5
  • McManus MJ, Welsch CW. The effects of estro-gen, progesterone and human placental lactogen on DNA synthesis on human breast ductal epithe-lium contained in athymic mice. Cancer 1984;54: 1920–7
  • Laidlaw IJ, Clarke RB, Howell A, et al. The prolif-eration of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 1995;136: 164–71
  • Longman SM, Buehring GC. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer 1995;59:281–7
  • Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcino-genesis. Breast Cancer Res Treat 1982;2:5–73
  • Cline JM, Soderqvist G, Von Shoultz B. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynolmogus macaques. Am J Obstet Gynecol 1996;174:93–100
  • Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P. Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 1981; 52:1225–9
  • Catherino WH, Jeng MH, Jordan VC. Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mecha-nism. Br J Cancer 1993;67:945–52
  • Catherino WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55:239–46
  • Desreux J, Noel A, Thomas JL, et al. Progestin induced apoptosis of normal human breast cells: an in vivo and in vitro study. Presented at the Eighth International Congress on the Menopause, Sydney, Australia, November 1996; abstr. F173:97
  • Musgrove EA, Lee CS, Sutherland RL. Progestins both stimulate and inhibit breast cancer cell progression while increasing expression of trans-forming growth factor receptor, c-fos and c-myc genes. Mol Cell Biol 1991;11:5032–43
  • Ferguson DJP, Anderson TJ. Morphological evalu-ation of cell turnover in relation to the menstrual cycle in the resting human breast. Br J Cancer 1991;44:177–81
  • Wren BG. Hormonal replacement therapy and breast cancer. Eur Menopause J1995;2:13–19
  • Chang KJ, Lee TTY, Linares-Cruz G, et al. Influ-ences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63:785–91
  • Foidart JM, Colin C, Denoo X, et al. Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 1998;69: 963–9
  • Pasqualini JR, Paris J, Sitruk-Ware R, et al. Progestins and breast cancer. J Steroid Biochem Mol Biol 1998;65:225–35
  • Pasqualini JR, Chetrite G, Nguyen BL, etal. Estrone sulfate-sulfatase and 17-b eta-hydroxysteroid dehydrogenase activities; a hypoth-esis for their role in the evolution of human breast cancer from hormone dependence to hormone independence. J Steroid Biochem Mol Biol 1995;53: 407–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.